Completion pneumonectomy for non-small cell lung cancer: experience with 59 cases

Terzi, Alberto; Lonardoni, A.; Falezza, G.; Scanagatta, Paolo; Santo, Antonio; Furlan, G.; Calabrò, Francesco

doi:10.1016/s1010-7940(02)00242-7

Cited by 23 publications

(13 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the overall postoperative mortality rate of 11.6% in our study is consistent with recently reported rates of 2.6-20.9% [2,5,6,[8][9][10][11][12][13][14][15][16][17][18][19][20] (Table 3). Thus, postoperative mortality is usually higher after CP than after standard pneumonectomy [1,9].…”

Section: Discussionsupporting

confidence: 92%

Factors affecting early and long-term outcomes after completion pneumonectomy☆

Chataigner

Fadel

Yıldızeli

et al. 2008

European Journal of Cardio-Thoracic Surgery

View full text Add to dashboard Cite

Although long-term survival was acceptable, postoperative mortality and morbidity rates remained high, confirming the reputation of completion pneumonectomy as a challenging procedure. Significant comorbidities and removal of the right lung were the main risk factors for postoperative mortality. Improved patient selection and better management of preoperative renal failure may improve the postoperative outcomes of this procedure, which offers a chance for prolonged survival.

show abstract

Section: Discussionsupporting

confidence: 92%

Factors affecting early and long-term outcomes after completion pneumonectomy☆

Chataigner

Fadel

Yıldızeli

et al. 2008

European Journal of Cardio-Thoracic Surgery

View full text Add to dashboard Cite

show abstract

“…Some reports have suggested that patients with a second primary lung cancer have a more favorable prognosis than patients with locally recurrent or metastatic disease (13-15). However, other reports did not reveal a significantly different survival between patients operated on for a second primary lung cancer or those patients operated on for locally recurrent or metastatic disease (4, 5, 8, 9). Our data showed that the 5-yr survival rates were not different between second primary lung cancer and the possible second primary or metastatic lung cancer.…”

Section: Discussionmentioning

confidence: 79%

“…Therefore, some researchers have insisted an aggressive surgical approach, whenever possible, as the survival rate after surgery is quite good (1-7). On the other hand, many doubts have been expressed concerning the utility of repeated surgery for recurrent lung cancer, as it is associated with a poor overall survival (8, 9). …”

Section: Introductionmentioning

confidence: 99%

Surgical Resection of Recurrent Lung Cancer in Patients Following Curative Resection

et al. 2006

View full text Add to dashboard Cite

We reviewed our experience with resection of recurrent lung cancer to evaluate the benefit and risk of the procedure. From December 1994 to December 2003, 29 consecutive patients underwent pulmonary resections for recurrent lung cancer. The mean duration from the first resection to second surgery was 25.4±15.1 months for the definite 2nd primary lung cancer (n=20) and 8.9±5.7 months for metastatic lung cancer (n=9). The procedures at the second operations were completion-pneumonectomy in 11 patients, lobectomy in 5 patients, wedge resection in 12 patients and resection and anastomosis of trachea in 1 patient. Morbidity was observed in 6 (21%) of the patients and the in-hospital mortality was two patients (7%) after the repeated lung resection. Tumor recurrence after reoperation was observed in 14 patients (48%). The actuarial 5-yr survival rate was 69% and the 5-yr disease free rate following reoperation was 44%. No significant difference was found in overall survival and disease free survival between the 2nd primary lung cancer group and the metastatic lung cancer group. The recurrence rate following reoperation was significantly different between the wedge resection group and lobectomy/completion pneumonectomy group ( p =0.008), but the survival rate was not significantly different ( p =0.41). Surgical intervention for recurrent lung cancers can be performed with acceptable mortality and morbidity. If tolerable, completion pneumonectomy or lobectomy is recommended for resection of recurrent lung cancer.

show abstract

“…[2][3][4][5][6][9][10][11][12][13][14][15][16][17] The overall 30-day mortality and late mortality rates of the current series were 14.8% and 22%, respectively, and the non-complication group had a much higher rate of mortality than the other group, although this was not statistically significant.…”

Section: Discussionmentioning

confidence: 98%

“…McGovern et al [2] 113 12.4 9.4 27.6 38.1 11.7 Van Schil et al [15] 19 15.8 10.5 Gregoire et al [3] [16] 66 7.6 53 7.6 Terzi et al [17] 59 3.4 3.4 30 Miller et al [14] 115 20.9 17.6 26.3 62.6 7 Guggino et al [13] 55…”

Section: Study No Overall Mortality (%) Malignant (%) Benign (%) Overmentioning

confidence: 99%

Does the indication for completion pneumonectomy affect outcome?

Akin¹,

Olcmen²,

İşgörücü³

et al. 2011

Turkish J Thorac Cardiovasc Surg

View full text Add to dashboard Cite

Amaç: Bu çalışmada 20 yıllık deneyimimiz gözden geçi-rildi ve tamamlayıcı pnömonektominin morbidite ve mortalite oranlarını etkileyen faktörler araştırıldı. Ça lış ma pla nı: Haziran 1987 ile Haziran 2008 tarihleri arasında 54 hastaya kliniğimizde tamamlayıcı pnömonek-tomi yapıldı. Hastalar tamamlayıcı pnömonektomi endikasyonları açısından önceki ameliyatın komplikasyonu ya da kalan akciğerde yeni bir hastalık gelişimi nedeni ile iki gruba ayrıldı. Bul gu lar: Genel komplikasyon oranı %42.5 idi ve bu morbidite komplikasyon grubunda anlamlı ölçüde daha yüksek idi (p= 0.04). Genel mortalite oranı %22 idi ve yaş mortalite için tek etkili faktör olarak bulundu (p= 0.03). So nuç: Yirmi yıllık deneyimimiz ve literatürdeki diğer bilgiler ışığında, tamamlayıcı pnömonektomide akıbeti kötü yönde etkileyen faktörün işlemin kendisinden ziyade, girişimin önceki ameliyatın komplikasyonu nedeni ile yapılması olduğu görüldü.Anah tar söz cük ler: Tamamlayıcı pnömonektomi; morbidite; mortalite. Background:In this report, we reviewed our 20-year experience and investigated the factors affecting morbidity and mortality of completion pneumonectomy. Methods: Fifty-four patients underwent completion pneumonectomy in our clinic between June 1987 and June 2008. Patients were divided into two groups according to their indications for completion pneumonectomy, either for a complication of the previous operation or a new disease in the remaining lung. Results: The overall complication rate was 42.5%, and this morbidity was significantly higher in the complication group (p=0.04). The overall mortality rate was 22%, and age was found as the only factor affecting mortality (p= 0.03). Conclusion:The experience that we had over 20 years and the other information from the literature pointed out that the complications in the first operations adversely affected the outcome rather than the procedure itself in completion pneumonectomy.

show abstract

Completion pneumonectomy for non-small cell lung cancer: experience with 59 cases

Cited by 23 publications

References 19 publications

Factors affecting early and long-term outcomes after completion pneumonectomy☆

Factors affecting early and long-term outcomes after completion pneumonectomy☆

Surgical Resection of Recurrent Lung Cancer in Patients Following Curative Resection

Does the indication for completion pneumonectomy affect outcome?

Contact Info

Product

Resources

About